These tools will no longer be maintained as of December 31, 2024. Archived website can be found here. PubMed4Hh GitHub repository can be found here. Contact NLM Customer Service if you have questions.


BIOMARKERS

Molecular Biopsy of Human Tumors

- a resource for Precision Medicine *

346 related articles for article (PubMed ID: 10852640)

  • 1. Pancreatic cancer: a review of emerging therapies.
    Rosenberg L
    Drugs; 2000 May; 59(5):1071-89. PubMed ID: 10852640
    [TBL] [Abstract][Full Text] [Related]  

  • 2. Biotherapeutic approaches to pancreatic cancer.
    Rosenberg L; Lipsett M
    Expert Opin Biol Ther; 2003 Apr; 3(2):319-37. PubMed ID: 12662145
    [TBL] [Abstract][Full Text] [Related]  

  • 3. Pancreatic cancer: does octreotide offer any promise?
    Rosenberg L
    Chemotherapy; 2001; 47 Suppl 2():134-49. PubMed ID: 11275707
    [TBL] [Abstract][Full Text] [Related]  

  • 4. Molecular therapy in pancreatic adenocarcinoma.
    MacKenzie MJ
    Lancet Oncol; 2004 Sep; 5(9):541-9. PubMed ID: 15337483
    [TBL] [Abstract][Full Text] [Related]  

  • 5. New therapeutic directions for advanced pancreatic cancer: cell cycle inhibitors, stromal modifiers and conjugated therapies.
    Matera R; Saif MW
    Expert Opin Emerg Drugs; 2017 Sep; 22(3):223-233. PubMed ID: 28783977
    [TBL] [Abstract][Full Text] [Related]  

  • 6. Current and Emerging Targeting Strategies for Treatment of Pancreatic Cancer.
    Baines AT; Martin PM; Rorie CJ
    Prog Mol Biol Transl Sci; 2016; 144():277-320. PubMed ID: 27865460
    [TBL] [Abstract][Full Text] [Related]  

  • 7. Current Systemic Treatment and Emerging Therapeutic Strategies in Pancreatic Adenocarcinoma.
    Yee NS; Kazi AA; Yee RK
    Curr Clin Pharmacol; 2015; 10(4):256-66. PubMed ID: 26548903
    [TBL] [Abstract][Full Text] [Related]  

  • 8. Adjuvant therapy for resectable pancreatic adenocarcinoma: review of the current treatment approaches and future directions.
    Antoniou G; Kountourakis P; Papadimitriou K; Vassiliou V; Papamichael D
    Cancer Treat Rev; 2014 Feb; 40(1):78-85. PubMed ID: 23810287
    [TBL] [Abstract][Full Text] [Related]  

  • 9. Translation of recent advances and discoveries in molecular biology and immunology in the diagnosis and treatment of pancreatic cancer.
    Albo D; Farrow B; Berger DH
    Surg Oncol Clin N Am; 2008 Apr; 17(2):357-76, ix. PubMed ID: 18375357
    [TBL] [Abstract][Full Text] [Related]  

  • 10. Review article: chemotherapy for pancreatic cancer.
    Shore S; Raraty MG; Ghaneh P; Neoptolemos JP
    Aliment Pharmacol Ther; 2003 Dec; 18(11-12):1049-69. PubMed ID: 14653825
    [TBL] [Abstract][Full Text] [Related]  

  • 11. Recent advances in the management of pancreatic adenocarcinoma.
    Karakas Y; Lacin S; Yalcin S
    Expert Rev Anticancer Ther; 2018 Jan; 18(1):51-62. PubMed ID: 29125367
    [TBL] [Abstract][Full Text] [Related]  

  • 12. Gene therapy for pancreatic cancer.
    Tseng JF; Mulligan RC
    Surg Oncol Clin N Am; 2002 Jul; 11(3):537-69. PubMed ID: 12487056
    [TBL] [Abstract][Full Text] [Related]  

  • 13. Current status of gene therapy for pancreatic cancer.
    Ramírez PJ; Vickers SM
    Curr Surg; 2004; 61(1):84-92. PubMed ID: 14972178
    [TBL] [Abstract][Full Text] [Related]  

  • 14. Perspectives in the treatment of pancreatic adenocarcinoma.
    Cid-Arregui A; Juarez V
    World J Gastroenterol; 2015 Aug; 21(31):9297-316. PubMed ID: 26309356
    [TBL] [Abstract][Full Text] [Related]  

  • 15. Pancreatic cancer: from molecular pathogenesis to targeted therapy.
    Strimpakos A; Saif MW; Syrigos KN
    Cancer Metastasis Rev; 2008 Sep; 27(3):495-522. PubMed ID: 18427734
    [TBL] [Abstract][Full Text] [Related]  

  • 16. Molecular targeted therapy for pancreatic adenocarcinoma: A review of completed and ongoing late phase clinical trials.
    Mosquera C; Maglic D; Zervos EE
    Cancer Genet; 2016 Dec; 209(12):567-581. PubMed ID: 27613577
    [TBL] [Abstract][Full Text] [Related]  

  • 17. Promising new therapies in advanced pancreatic adenocarcinomas.
    Kundranda M; Kachaamy T
    Future Oncol; 2014 Dec; 10(16):2629-41. PubMed ID: 25531049
    [TBL] [Abstract][Full Text] [Related]  

  • 18. Therapeutic developments in pancreatic cancer: current and future perspectives.
    Neoptolemos JP; Kleeff J; Michl P; Costello E; Greenhalf W; Palmer DH
    Nat Rev Gastroenterol Hepatol; 2018 Jun; 15(6):333-348. PubMed ID: 29717230
    [TBL] [Abstract][Full Text] [Related]  

  • 19. Pharmacogenetics of anticancer drug sensitivity in pancreatic cancer.
    Giovannetti E; Mey V; Nannizzi S; Pasqualetti G; Del Tacca M; Danesi R
    Mol Cancer Ther; 2006 Jun; 5(6):1387-95. PubMed ID: 16818496
    [TBL] [Abstract][Full Text] [Related]  

  • 20. Prevailing over T cell exhaustion: New developments in the immunotherapy of pancreatic cancer.
    Bauer C; Kühnemuth B; Duewell P; Ormanns S; Gress T; Schnurr M
    Cancer Lett; 2016 Oct; 381(1):259-68. PubMed ID: 26968250
    [TBL] [Abstract][Full Text] [Related]  

    [Next]    [New Search]
    of 18.